open access

Vol 1, No 1 (2016)
Original article
Published online: 2016-08-11
Get Citation

Mild therapeutic hypothermia for patients with acute coronary syndrome and cardiac arrest treated with percutaneous coronary intervention (UNICORN). The design and rationale for the prospective, observational, multicenter study

Julia Maria Kubica, Krzysztof Pstrągowski, Piotr Adamski, Michał Kasprzak, Ewa Obońska, Karolina Obońska, Anita Dąbrowska, Salvatore Di Somma, Andrzej Kleinrok, Marcin Gruchała, Piotr Kasztelowicz, Przemysław Sobczak, Przemysław Paciorek, Marek Koziński, Jacek Kubica
·
Medical Research Journal 2016;1(1):23-27.

open access

Vol 1, No 1 (2016)
ORIGINAL ARTICLES
Published online: 2016-08-11

Abstract

Introduction. Cardiac arrest constitutes the most frequent reason for sudden death in developed countries. Out-of-hospital cardiac arrest (OHCA) survivors are at high risk of death or neurologic deficits. The existing data regarding effectiveness and safety of mild therapeutic hypothermia (MTH) for treatment of OHCA survivors are inconsistent and ambiguous. Moreover, a uniform protocol of treatment by means of MTH is lacking.

Methods. The UNICORN study is a phase IV, prospective, international, multi-centre, observational study designed to assess the effectiveness of MTH in patients after OHCA with shockable rhythm presenting with acute coronary syndrome (ACS). The trial is expected to include up to 500 patients. Depending on the availability of MTH in each study centre, besides the routine treatment of ACS in OHCA survivors, patients will either undergo MTH according to a uniform protocol or will not undergo MTH (250 patients per group). The primary end-point of the study is all cause mortality at 180 days after enrolment. Secondary end-points include: neurological outcome at discharge, stent thrombosis at 30 days, bleeding according to the BARC criteria, infectious complications at 180 days, and rhythm and conduction disorders at 180 days.

Ethics and dissemination. The study received approval from the Local Ethics Committee to conduct the study (Komisja Bioetyczna Uniwersytetu Mikołaja Kopernika w Toruniu przy Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; study approval reference number KB 615/2015). The study results will be disseminated through conference presentations and publications in peer-reviewed journals.

Trial registration. ClinicalTrials.gov identifier: NCT02611934 (18 November 2015).  

Abstract

Introduction. Cardiac arrest constitutes the most frequent reason for sudden death in developed countries. Out-of-hospital cardiac arrest (OHCA) survivors are at high risk of death or neurologic deficits. The existing data regarding effectiveness and safety of mild therapeutic hypothermia (MTH) for treatment of OHCA survivors are inconsistent and ambiguous. Moreover, a uniform protocol of treatment by means of MTH is lacking.

Methods. The UNICORN study is a phase IV, prospective, international, multi-centre, observational study designed to assess the effectiveness of MTH in patients after OHCA with shockable rhythm presenting with acute coronary syndrome (ACS). The trial is expected to include up to 500 patients. Depending on the availability of MTH in each study centre, besides the routine treatment of ACS in OHCA survivors, patients will either undergo MTH according to a uniform protocol or will not undergo MTH (250 patients per group). The primary end-point of the study is all cause mortality at 180 days after enrolment. Secondary end-points include: neurological outcome at discharge, stent thrombosis at 30 days, bleeding according to the BARC criteria, infectious complications at 180 days, and rhythm and conduction disorders at 180 days.

Ethics and dissemination. The study received approval from the Local Ethics Committee to conduct the study (Komisja Bioetyczna Uniwersytetu Mikołaja Kopernika w Toruniu przy Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; study approval reference number KB 615/2015). The study results will be disseminated through conference presentations and publications in peer-reviewed journals.

Trial registration. ClinicalTrials.gov identifier: NCT02611934 (18 November 2015).  

Get Citation

Keywords

acute coronary syndrome, out-of-hospital cardiac arrest, percutaneous coronary intervention, therapeutic hypothermia

About this article
Title

Mild therapeutic hypothermia for patients with acute coronary syndrome and cardiac arrest treated with percutaneous coronary intervention (UNICORN). The design and rationale for the prospective, observational, multicenter study

Journal

Medical Research Journal

Issue

Vol 1, No 1 (2016)

Article type

Original article

Pages

23-27

Published online

2016-08-11

Page views

870

Article views/downloads

977

DOI

10.5603/MRJ.2016.0004

Bibliographic record

Medical Research Journal 2016;1(1):23-27.

Keywords

acute coronary syndrome
out-of-hospital cardiac arrest
percutaneous coronary intervention
therapeutic hypothermia

Authors

Julia Maria Kubica
Krzysztof Pstrągowski
Piotr Adamski
Michał Kasprzak
Ewa Obońska
Karolina Obońska
Anita Dąbrowska
Salvatore Di Somma
Andrzej Kleinrok
Marcin Gruchała
Piotr Kasztelowicz
Przemysław Sobczak
Przemysław Paciorek
Marek Koziński
Jacek Kubica

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl